lung
inflamm
critic
event
pathogenesi
variou
diseas
includ
asthma
chronic
obstruct
pulmonari
diseas
copd
sever
acut
respiratori
syndrom
sar
cancer
increas
level
adhes
molecul
might
contribut
recruit
pmn
variou
region
lung
inflamm
process
intercellular
adhes
one
import
adhes
molecul
mediat
tight
adhes
pmn
facilit
pmn
migrat
across
vascular
endothelium
barrier
interact
lung
epithelium
reduc
express
lung
epithelium
current
consid
novel
therapeut
approach
manag
respiratori
diseas
previous
upregul
cytokin
shown
regul
phosphoryl
three
mapk
well
transcript
factor
nuclear
factor
activ
protein
lung
epitheli
cell
recent
increas
evid
shown
nadph
oxidas
nox
deriv
ro
gener
modifi
signal
oxid
reactiv
cystein
within
certain
cell
signal
molecul
especi
mapk
transcript
factor
nox
famili
rosproduc
enzym
increasingli
recogn
major
sourc
ro
cell
least
seven
nox
isoform
identifi
name
isoform
distinguish
accord
tissu
distribut
structur
mode
activ
known
first
isoform
discov
extens
studi
nox
member
activ
partial
regul
assembl
catalyt
subunit
regulatori
subunit
small
gtpase
rac
enzym
catalyz
transfer
electron
nadph
molecular
oxygen
gener
superoxid
anion
form
ro
byproduct
highli
express
phagocyt
express
also
detect
variou
cell
includ
lung
epithelium
moreov
elev
level
ro
shown
activ
signal
transduct
cascad
drive
express
adhes
molecul
endotheli
cell
epitheli
cell
fibroblast
astrocyt
thu
blockad
ro
product
may
select
target
reduc
neutrophil
adhes
adhes
molecul
suppress
attenu
inflammatori
respons
lung
diseas
curcumin
natur
occur
phenol
compound
found
curcuma
longa
shown
possess
potent
antioxid
antiinflammatori
antitumor
activ
regul
multipl
transcript
factor
cytokin
growth
factor
kinas
enzym
howev
curcumin
low
bioavail
attribut
poor
aqueou
solubl
dissolut
properti
nanon
serv
mechan
circumv
limit
facilit
product
curcumin
nanoparticl
highli
watersolubl
increas
water
solubl
may
also
increas
biodistribut
bioavail
curcumin
potenti
slow
rapid
metabol
system
elimin
util
polyvinylpyrrolidon
pvp
develop
novel
curcumin
nanoparticl
system
curn
pvp
strong
hydrophil
polym
extens
util
improv
solubl
bioavail
compound
poor
watersolubl
delay
crystal
compound
form
molecular
adduct
previou
studi
demonstr
physicochem
properti
curcumin
use
pvp
nanoparticl
system
improv
includ
reduct
compound
particl
size
format
highenergi
amorph
state
induct
intermolecular
hydrogen
bond
altogeth
enhanc
water
solubl
drug
releas
moreov
improv
drug
releas
enhanc
antioxid
anticanc
effect
curn
hepatocyt
compar
cur
water
prepar
studi
evalu
effect
curn
express
lung
epitheli
cell
subsequ
lung
inflamm
mice
comparison
inhibitori
effect
curcumin
water
curh
effect
associ
inhibit
ro
gener
decreas
mapk
activ
transcript
factor
bind
activ
recombin
human
r
system
minneapoli
mn
usa
antiphospho
cfo
anti
phospho
cjun
antibodi
santa
cruz
santa
cruz
ca
usa
antiphospho
antibodi
assay
biotechnolog
compani
sunnyval
ca
usa
antiphospho
mapk
antiphospho
mapk
antiphospho
antibodi
cell
signal
danver
usa
diphenyleneiodonium
chlorid
dpi
tanshinon
iia
curcumin
biomol
plymouth
meet
pa
usa
bicinchonin
acid
bca
protein
assay
kit
pierc
rockford
il
usa
curcuminload
polyvinylpyrrolidon
nanoparticl
curn
prepar
describ
previous
molecular
probe
eugen
usa
apocynin
apo
chromadex
santa
ana
ca
usa
luciferas
assay
kit
promega
madison
wi
usa
nacetyllcystein
nac
chemic
sigma
st
loui
mo
usa
cell
human
lung
epitheli
cell
carcinoma
purchas
food
industri
research
develop
institut
taiwan
cultur
supplement
fb
antibiot
uml
penicillin
g
mgml
streptomycin
ngml
fungizon
humidifi
atmospher
cultur
reach
confluenc
day
cell
treat
wv
min
cell
suspens
dilut
contain
fb
concentr
cellsml
cell
suspens
plate
onto
mlwell
cultur
plate
mldish
cultur
dish
measur
protein
express
mrna
accumul
respect
cultur
medium
chang
h
everi
day
growtharrest
cell
incub
indic
time
cell
wash
scrape
collect
centrifug
h
yield
whole
cell
extract
previous
describ
sampl
denatur
subject
sdspage
use
run
gel
transfer
nitrocellulos
membran
membran
incub
anticfo
anticjun
antiphospho
mapk
antiphospho
mapk
antiphospho
antibodi
antibodi
h
membran
incub
antimous
rabbit
horseradish
peroxidas
antibodi
h
immunoreact
band
detect
ecl
reagent
develop
hyperfilmecl
total
rna
isol
trizol
accord
protocol
manufactur
cdna
obtain
total
rna
use
templat
pcr
amplif
previous
describ
lee
et
al
primer
use
follow
sens
antisens
sens
antisens
human
firefli
luciferas
kindli
provid
dr
p
van
der
saag
hubrecht
laboratori
utrecht
netherland
activ
determin
previous
describ
use
luciferas
assay
system
promega
madison
wi
usa
firefli
luciferas
activ
standard
activ
cell
harvest
sonic
output
sonic
misonix
farmingdal
ny
centrifug
rpm
min
pellet
collect
nuclear
fraction
use
cfo
cjun
assay
supernat
centrifug
rpm
min
yield
pellet
membran
fraction
supernat
cytosol
fraction
use
phox
assay
bal
fluid
determin
previous
describ
mice
inject
dose
mgkg
sacrif
h
later
bal
fluid
administ
tracheal
cannula
use
aliquot
icecold
phosphatebuff
salin
pb
medium
bal
fluid
centrifug
g
cell
pellet
wash
resuspend
pb
leukocyt
count
determin
hemocytomet
smartpool
rna
duplex
correspond
human
scrambl
sirna
santa
cruz
biotechnolog
ca
usa
transient
transfect
sirna
carri
use
transfect
reagent
sirna
nm
formul
transfect
reagent
accord
manufactur
instruct
transfect
effici
approxim
determin
transfect
egfp
detect
ro
product
effect
curn
superoxid
anion
product
cell
determin
fluorimetr
assay
use
dihydroethidium
dhe
amplex
red
probe
respect
confluent
cell
incub
without
curn
curh
h
dpi
h
cell
incub
dhe
min
amplex
redhrp
min
ngml
ad
well
indic
time
fluoresc
densiti
rel
fluoresc
unit
detect
nm
nm
excitationemiss
respect
ethidium
correspond
resorufin
use
multidetect
reader
spectramax
molecular
devic
sunnyval
ca
usa
plasma
membran
prepar
nox
activ
assay
western
blot
analysi
phox
phox
cytosol
plasma
membran
fraction
prepar
describ
previous
modif
briefli
cell
lyse
lysi
buffer
mm
mm
egta
mm
edta
mm
dithiothreitol
mm
phenylmethylsulfonyl
fluorid
pmsf
aprotinin
leupeptin
cell
lysat
centrifug
g
min
supernat
collect
design
cytosol
fraction
pellet
resuspend
lysi
buffer
b
sodium
dodecyl
sulfat
mm
mmpmsf
aprotinin
leupeptin
western
blot
analysi
phox
phox
perform
plasma
membran
fraction
describ
use
monoclon
mous
antibodi
phox
phox
nox
activ
assay
cell
lyse
lysi
buffer
contain
mm
monobas
potassium
phosphat
ph
mm
egta
aprotinin
leupeptin
mm
pmsf
plasma
membran
fractionswer
measur
lucigenin
chemiluminesc
assay
use
mm
lucigenin
sigma
mm
nadph
sigma
describ
prepar
nuclear
protein
extract
emsa
condit
describ
previous
nuclear
protein
extract
use
neper
reagent
pierc
rockford
il
usa
accord
manufactur
protocol
bind
activ
equal
amount
nuclear
protein
analyz
use
lightshift
chemiluminesc
emsa
kit
pierc
synthet
doublestrand
oligonucleotid
use
probe
gelshift
assay
cell
grown
confluenc
plate
incub
h
adhes
assay
perform
briefli
cell
origin
deriv
human
histiocyt
lymphoma
obtain
american
type
cultur
collect
rockvil
md
usa
grown
rpmi
medium
gibco
brl
grand
island
ny
label
h
bcecfam
mm
boehring
mannheim
mannheim
germani
subsequ
wash
centrifug
confluent
cell
plate
incub
cell
cellsml
h
nonadher
cell
remov
plate
gentli
wash
twice
pb
number
adher
cell
determin
count
four
field
per
highpow
field
well
use
fluoresc
microscop
zeiss
axiovert
experi
perform
triplic
repeat
least
three
time
male
mice
n
weigh
g
purchas
nation
taiwan
univers
taipei
taiwan
automat
control
temperatur
light
cycl
fed
standard
laboratori
chow
tap
water
ad
libitum
procedur
involv
experiment
anim
use
studi
review
approv
anim
use
committe
nation
taiwan
univers
indic
investig
conform
us
nih
guidelin
care
use
laboratori
anim
nih
public
revis
mice
randomli
divid
four
group
salin
group
administr
curn
curh
curn
powder
ad
normal
salin
sonic
min
prepar
curh
made
method
mice
anesthet
intraperiton
ip
inject
curn
curh
mgkg
salin
h
mgkg
place
posterior
throat
aspir
lung
h
mice
sacrif
intraperiton
inject
overdos
pentobarbit
lung
dissect
immersionfix
buffer
paraformaldehyd
paraffinembed
crosssect
immunohistochemstri
specimen
incub
antibodi
santa
cruz
ca
hr
wash
pb
incub
hrpconjug
goat
antirabbit
igg
dilut
sigma
bound
antibodi
visual
use
diaminobenzidin
sigmaaldrich
st
loui
mo
section
stain
hematoxylineosin
addit
also
determin
curcumin
lung
tissu
distribut
curn
curh
treatment
verifi
curcumin
deposit
lung
lung
tissu
homogen
acetonitril
extract
curcumin
curcumin
lung
tissu
conduct
accord
modifi
procedur
describ
previous
hplc
system
consist
pump
uvvi
detector
autosampl
separ
perform
lichrocart
purosph
star
mm
id
mobil
phase
mm
potassium
dihydrogen
phosphat
buffer
acetonitril
flow
rate
mlmin
uv
wavelength
set
nm
data
estim
made
use
graphpad
prism
program
graphpad
san
diego
ca
usa
data
express
analyz
oneway
anova
follow
tukey
posthoc
test
p
consid
signific
cytotox
test
curn
cell
use
bromid
assay
treatment
show
chang
cell
viabil
fig
also
compar
effect
curn
curh
express
shown
fig
protein
express
significantli
inhibit
pretreat
curn
respons
follow
dosedepend
manner
similar
result
also
observ
human
pulmonari
microvascular
endotheli
cell
data
show
addit
mrna
express
promot
activ
also
reduc
pretreat
curn
fig
howev
effect
observ
insolubl
curcumin
curh
pvp
void
nanoparticl
fig
compar
function
consequ
curn
curh
treatment
perform
cell
adhes
assay
use
cell
monocyt
adher
cell
pretreat
h
number
adher
cell
dramat
decreas
pretreat
curn
curh
fig
addit
adhes
activ
also
block
dpi
inhibitor
nox
tanshinon
iia
inhibitor
result
suggest
pretreat
curn
inhibit
lung
inflammatori
respons
may
regul
inhibit
hand
express
might
mediat
nox
cell
enhanc
interact
ro
implic
initi
inflammatori
respons
airway
activ
transcript
factor
lead
elev
level
express
adhes
molecul
nox
enzymat
sourc
product
ro
variou
patholog
condit
ascertain
gener
ro
involv
express
cell
affect
curn
fluoresc
probe
dcfda
use
determin
gener
ro
cell
cell
label
dcfda
treat
min
fluoresc
intens
rel
dcf
fluoresc
measur
excit
wavelength
nm
emiss
wavelength
nm
shown
fig
ro
gener
significantli
attenu
pretreat
curn
dpi
apo
inhibitor
wherea
similar
effect
observ
curh
pretreat
ro
scaveng
nac
dpi
apo
also
markedli
inhibit
protein
express
fig
moreov
consist
membran
catalyt
subunit
togeth
sever
cytosol
regulatori
subunit
small
gtpase
rac
regulatori
subunit
play
critic
role
acut
activ
nox
present
studi
show
induc
phosphoryl
transloc
cytosol
membran
within
min
effect
inhibit
curn
apo
fig
howev
curh
show
effect
phosphoryl
transloc
moreov
pretreat
curn
dpi
apo
also
result
reduct
nadph
oxidas
activ
respons
cell
fig
final
perform
experi
use
sirna
phox
shown
fig
f
transfect
sirna
phox
inhibit
express
respons
result
thu
show
curn
curh
reduc
express
inhibit
gener
cell
indic
curn
exert
better
antioxid
activ
curh
kinas
mapk
akt
src
protein
phosphatas
compon
redoxsensit
signal
pathway
may
target
noxderiv
ro
thu
effect
curn
pretreat
mapk
phosphoryl
compar
curh
shown
fig
phosphoryl
significantli
attenu
respect
furthermor
pretreat
curn
nac
dpi
also
result
signific
decreas
mapk
phosphoryl
wherea
similar
effect
observ
use
curh
result
suggest
curn
impart
stronger
inhibitori
effect
curh
mapk
phosphoryl
result
inhibit
pathway
cell
gene
promot
contain
consensu
bind
site
investig
whether
curn
inhibit
express
transcript
factor
compar
effect
use
curh
gelshift
assay
perform
determin
effect
curn
curh
activ
cell
shown
fig
low
basal
level
bind
activ
detect
untreat
control
cell
wherea
bind
significantli
increas
treatment
min
pretreat
curn
h
inhibit
increas
bind
activ
wherea
similar
result
observ
use
curh
also
enhanc
bind
activ
although
differ
observ
use
curn
curh
data
shown
pretreat
inhibitor
tanshinon
iia
result
signific
decreas
express
respons
occur
dosedepend
manner
fig
c
addit
transcript
complex
compos
least
two
major
factor
cfo
cjun
phosphoryl
cfo
cjun
detect
stimul
fig
pretreat
curn
dpi
result
signific
decreas
cfo
cjun
phosphoryl
wherea
similar
effect
observ
curh
result
suggest
curn
impart
greater
inhibitori
effect
express
block
activ
determin
antiinflammatori
effect
curcumin
nanoparticl
vivo
mice
intraperiton
inject
curn
curh
mgkg
h
treat
mgkg
h
illustr
fig
induc
express
brown
color
wherea
inject
curn
curh
effect
decreas
express
alveolar
wall
histolog
examin
show
thicken
alveolar
wall
increas
amount
alveolar
hemorrhag
greater
number
infiltr
inflammatori
cell
fig
moreov
also
perform
bronchoalveolar
lavag
bal
measur
pmn
influx
shown
fig
significantli
enhanc
express
leukocyt
eosinophil
neutrophil
count
bal
fluid
mice
attenu
intraperiton
curn
curh
contrast
preadministr
curn
show
greater
inhibitori
effect
lung
inflamm
decreas
stain
anim
result
indic
curn
better
antiinflammatori
effect
compar
observ
curh
confirm
curcumin
distribut
lung
tissu
singl
dose
curn
cruh
mice
lung
injuri
use
hplc
analysi
determin
curcumin
level
curn
curh
lung
tissu
shown
fig
curcumin
distribut
lung
tissu
curcumin
level
nggm
hplc
chromatographi
curhtreat
lung
tissu
show
curcumin
signal
wherea
curcumin
level
detect
limit
base
find
curn
distribut
greater
amount
curcumin
lung
tissu
compar
curh
also
determin
curcumin
level
lung
tissu
higher
curn
compar
use
curh
tabl
find
indic
curn
increas
curcumin
uptak
lung
cell
result
better
antioxid
antiinflammatori
activ
compar
use
curh
dietari
polyphenol
curcumin
could
effect
use
prevent
aggrav
mani
diseas
virtu
biolog
pharmacolog
activ
commonli
use
spice
food
preserv
nontox
agent
extens
research
last
past
five
decad
reveal
curcumin
possess
antioxid
antiinflammatori
anticancer
antimicrobi
antiparasit
anticholesterol
antimutagen
properti
woundheal
properti
cardiovascular
hepat
neuron
protect
activ
howev
low
level
water
solubl
curcumin
becom
major
limit
factor
preclin
dissolut
test
drug
health
food
applic
thu
curcumin
exhibit
therapeut
effect
human
bodi
person
requir
swallow
g
curcumin
per
day
decad
nanotechnolog
platform
wide
use
creat
deliveri
system
natur
product
nutraceut
poor
water
solubl
previou
studi
util
pvp
develop
curn
previou
report
describ
enhanc
antioxid
anticanc
effect
curn
hepatocyt
compar
curcumin
water
prepar
current
studi
analyz
inhibitori
effect
curn
express
vitro
lung
epitheli
cell
vivo
lung
epithelium
mice
effect
also
compar
use
curh
relat
rosderiv
mapk
pathway
result
studi
show
curn
decreas
express
inhibit
nadph
oxidas
nox
deriv
ro
gener
reduc
mapk
transcript
factor
bind
activ
compar
analysi
antiinflammatori
effect
curn
curh
lung
epitheli
cell
show
significantli
greater
inhibit
express
gene
protein
level
fig
howev
express
attenu
curh
pvp
void
nanoparticl
fig
function
activ
assay
curn
show
inhibit
bind
activ
human
histiocyt
lymphoma
cell
line
lung
epitheli
cell
similar
effect
observ
use
curh
treatment
fig
vivo
studi
perform
bal
fluid
isol
mice
also
show
curn
reduc
pmn
influx
effect
also
shown
treatment
antibodi
fig
although
curn
treatment
result
decreas
express
fig
partial
affect
monocyt
adhes
fig
leukocyt
infiltr
fig
thu
factor
may
also
associ
express
vascular
adhes
molecul
selectin
put
function
group
curcumin
benzen
ring
adjac
methoxyhydroxyl
group
serv
potent
inhibitor
nox
activ
interestingli
pretreat
dpi
inhibitor
nox
caus
signific
reduct
interact
result
suggest
curn
inhibit
express
potent
antioxid
properti
compar
antioxid
activ
curn
curh
express
upon
stimul
lung
tissu
expos
oxid
stress
nox
isoform
repres
major
sourc
ro
within
respiratori
system
ro
also
shown
mediat
express
airway
present
data
pretreat
curn
dpi
apo
markedli
reduc
ro
gener
nox
activ
similar
effect
observ
curh
treatment
fig
addit
antioxid
nac
dpi
apo
also
inhibit
express
suggest
ro
regul
effect
express
fig
nox
multisubunit
enzymat
complex
respons
product
superoxid
caus
monoelectron
reduct
oxygen
use
nadph
nadh
addit
robustli
express
lung
alveolar
epitheli
cell
involv
regul
epitheli
cell
function
gener
robust
evid
transfect
sirna
phox
block
express
respons
fig
f
although
play
critic
role
lung
inflamm
may
influenc
express
epitheli
cell
also
express
speci
nox
key
player
epitheli
cell
death
lead
pulmonari
fibrosi
acut
lung
injuri
whether
involv
lung
inflamm
need
investig
futur
moreov
phosphoryl
act
organ
complex
facilit
assembl
transloc
bind
cytosol
subunit
catalyt
complex
therefor
compar
effect
curn
curh
activ
shown
fig
curn
apo
potent
inhibitori
effect
activ
includ
phosphoryl
transloc
cytosol
membran
within
min
treatment
contrast
curh
show
effect
phosphoryl
transloc
result
suggest
curn
reduc
express
inhibit
nadph
oxidas
activ
phox
activ
membran
fraction
cell
thu
exert
stronger
antioxid
activ
curh
previou
studi
ro
shown
modul
downstream
signal
transduct
mapk
mapk
consist
three
major
member
name
erk
jnk
famili
serinethreonin
kinas
control
cellular
respons
growth
apoptosi
inflamm
stress
signal
upregul
cytokin
shown
mediat
activ
mapk
cell
studi
compar
effect
curn
curh
phosphoryl
mapk
found
pretreat
result
decreas
phosphoryl
respect
fig
addit
also
demonstr
ro
involv
mapk
phosphoryl
cell
treat
antioxid
nac
dpi
data
also
show
curn
curh
markedli
inhibit
mapk
phosphoryl
may
mediat
potent
antioxid
activ
mapk
shown
phosphoryl
transcript
factor
intracellular
enzym
includ
transcript
factor
shown
regul
express
induc
thu
first
confirm
involv
express
incub
inhibitor
tanshinon
iia
shown
fig
c
moreov
gelshift
assay
demonstr
bind
promot
increas
pretreat
curn
significantli
attenu
bind
activ
fig
data
shown
possibl
mechan
underli
effect
curcumin
inhibit
remain
investig
furthermor
function
dimer
form
cfoscjun
cjuncjun
examin
effect
curn
curh
cfo
cjun
phosphoryl
shown
fig
cfo
cjun
phosphoryl
markedli
inhibit
curn
dpi
effect
found
treatment
curh
base
find
previou
report
curn
show
greater
inhibitori
effect
curh
express
attribut
inhibit
pathway
cell
addit
vitro
studi
previou
result
shown
pvpload
novel
nanoparticl
system
enhanc
dissolut
properti
curcumin
reduc
particl
size
improv
physicochem
characterist
crucial
factor
achiev
optim
vivo
efficaci
therefor
present
studi
also
measur
curcumin
level
lung
confirm
distribut
curn
curh
treatment
result
tabl
demonstr
intraperiton
inject
curn
result
higher
curcumin
level
distribut
lung
compar
use
curh
find
suggest
curn
increas
cell
uptak
lung
show
better
antioxid
antiinflammatori
activ
curh
present
studi
examin
anim
model
express
inflammatori
cell
infiltr
establish
superior
curn
curh
pulmonari
protect
effect
fig
b
may
attribut
effect
antioxid
antiinflammatori
activ
consequ
suggest
curn
deserv
studi
may
potenti
use
prophylaxi
inflammatori
pulmonari
diseas
